Bills · S 2285
IN COMMITTEE· 119TH CONGRESS
Senate BillS 2285Health
Uterine Cancer Study Act of 2025
INTRO JUL 15· LAST ACTION JUL 15
READING
2MIN
COSPONSORS
2
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it addresses a significant public health concern, particularly for women of color who face disproportionately higher rates of uterine cancer. There's growing scientific interest in the potential link between chemical hair products and adverse health outcomes, and this study would provide critical, government-backed research on the topic.
If this bill becomes law, it could lead to better consumer awareness about potential risks, safer product formulations, or even new regulatory standards for hair straighteners. If it doesn't pass, this specific, focused study might not happen, leaving a gap in understanding a potential health disparity and delaying any potential actions to protect public health related to these products.
KEY PROVISIONS
5AI-extractedPROVISION 01
Directs the Secretary of Health and Human Services to conduct a study on the relationship between hair straighteners and uterine cancer.
This initiates a federal investigation into a potential health risk associated with commonly used products.
PROVISION 02
Requires the study to focus specifically on the increased incidence of uterine cancer among women of color.
This addresses a critical health disparity and ensures research is targeted to a disproportionately affected group.
PROVISION 03
Mandates that the study disaggregate results based on whether hair straighteners contain dyes, coloring, bleach, highlights, or perms.
This allows for a more detailed understanding of which specific product components might be linked to health risks.
PROVISION 04
Requires the study to determine if the Food and Drug Administration (FDA) should impose additional testing requirements on manufacturers of hair straightening products.
This provision aims to provide recommendations for potential regulatory changes to enhance product safety.
PROVISION 05
Sets deadlines for submitting a study methodology (45 days), commencing the study (180 days), and submitting a final report to Congress (2 years).
These deadlines ensure the study is conducted and reported in a timely manner.
SPONSORSHIP
1 + 2
D· Delaware
YRS IN OFFICE
9
BILLS LED
43
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 2 REP 0 IND 0
ACTION TIMELINE
2 EVENTSJUL 15
Introduced in Senate
JUL 15
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 2285
Congress119th
StatusIn Committee
IntroducedJul 15, 2025
Last actionJul 15, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED JUL 15, 2025
Senate BillS 2285Health
Uterine Cancer Study Act of 2025
INTRODUCED JUL 15, 2025· LAST ACTION JUL 15, 2025
PASSAGE CHANCES
—%
READING
2 min
COSPONSORS
2
COMPLEXITY
Moderate
